NCT05752552
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05752552
Title Study to Determine the Safety and Pharmacokinetics of DO-2 in Patients With Advanced or Refractory Solid Tumours
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors DeuterOncology
Indications
Therapies
Age Groups: senior | adult
Covered Countries NLD | FRA | BEL

Facility Status City State Zip Country Details
Institut Roi Albert II - UC Louvain RECRUITING Brussels Belgium Details
UZA RECRUITING Edegem Belgium Details
Universitair Ziekenhuis Gent RECRUITING Ghent 9000 Belgium Details
UZ Leuven RECRUITING Leuven Belgium Details
Institut Bergonie RECRUITING Bordeaux France Details
Institut Cœur Poumon - CHU Lille RECRUITING Lille France Details
Centre Léon Bérard RECRUITING Lyon France Details
Hôpitaux Universitaires de Marseille Timone NOT_YET_RECRUITING Marseille 13385 France Details
Centre Antoine Lacassagne NOT_YET_RECRUITING Nice France Details
Centre Hospitalier Universitaire De Rennes RECRUITING Rennes France Details
Institut Gustave Roussy NOT_YET_RECRUITING Villejuif France Details
Radboud UMC RECRUITING Nijmegen Netherlands Details
Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC) RECRUITING Rotterdam Netherlands Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field